Optio attends CHDI – February 2022, Palm Springs, USA

Optio attends the 2022 CHDI in-person conference in Palm Springs. CHDI is the premier scientific conference advancing therapeutic options for Huntington’s disease (HD). Optio Biopharma Solutions is a leading rare disease pharmaceutical commercial services agency committed to staying current on scientific and clinical developments in HD.



Leave a Reply